Company Research Report: Surescripts
Company Overview
- Name: Surescripts
- Mission: Surescripts aims to simplify health intelligence sharing to increase patient safety, lower costs, and ensure quality care.
- Foundation: No information is available.
- Founders: No information is available.
- Key People:
- Frank Harvey - Chief Executive Officer
- Tara Dragert - Chief Product Officer
- Headquarters: Arlington, Virginia, USA
- Number of Employees: No information is available.
- Revenue: No information is available.
- Known For: Surescripts is known for pioneering innovations in electronic prescribing and enabling reliable, secure, and scalable health intelligence sharing across the U.S. healthcare industry.
Products and Services
- Products Offered:
- Care Event Notifications
- Electronic Prescribing for Controlled Substances
- Formulary
- Medication History for Populations
- Record Locator & Exchange
- Therapeutic Alternatives
- Clinical Direct Messaging
- Electronic Prior Authorization
- On-Demand Formulary
- Medication History for Reconciliation
- Specialty Medications Gateway
- E-Prescribing
- Eligibility
- Medication History for Ambulatory
- Real-Time Prescription Benefit
- Specialty Patient Enrollment
- Product Descriptions and Key Features:
- Sig IQ Technology: Automatically translates free-text patient directions into a structured and codified format, reducing uncertainty, improving prescription accuracy, and minimizing the risk of patient harm.
- Medication History for Populations: Provides comprehensive medication data to help healthcare providers identify care gaps, improve medication adherence, and support better care outcomes.
- Real-Time Prescription Benefit: Offers cost savings insights, helping prescribers find less costly medication alternatives which average $37 savings per prescription.
Recent Developments
- New Products and Features:
- Sig IQ Expansion (2024): Surescripts expanded Sig IQ technology to e-prescribing transactions, improving patient safety and clinician efficiency.
- Medication History for Populations Expansion (2024): Expanded support to health plans to enhance visibility into patient medication histories, aiming to reduce care gaps and improve patient outcomes.
- Partnerships:
- TPG Investment (2024): TPG joined Surescripts' ownership group as a majority investor, marking significant growth for the company.
- Strategic Partnership with CLEAR (2024): Enhanced identity verification technology infrastructure.
- Awards:
- Surescripts White Coat Award (2024): Recognizes leaders in prescription accuracy and innovation.
- Impact and Achievements:
- In 2023, Surescripts exchanged 23.8 billion healthcare network transactions.
- Improved patient safety by significantly reducing transcription errors through Sig IQ technology.
- Increased medication history responses augmented by 85% in 2023.
This report details Surescripts' initiatives and accomplishments in the healthcare information network industry, emphasizing its ceaseless innovation and comprehensive service offerings that enhance patient safety and streamline healthcare operations.
